Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiden Haghikia

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2016
Active immunotherapy may delay disability in progressive MSAiden Haghikia, Ralf Gold
MMW Fortschritte Der Medizin|September 7, 2013
[Multiple sclerosis: oral drugs]Aiden Haghikia, Ralf Gold
European Journal of Neurology|February 9, 2021
From many, one: A call for meta-cohorts in neuromuscular ultrasoundStefanie Schreiber, Aiden Haghikia
JAMA Neurology|March 9, 2016
Positive Effect on Multiple Sclerosis With Treatment of Metabolic SyndromeAiden Haghikia, Ralf Gold
Experimental Neurology|April 14, 2009
Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?Aiden Haghikia, Ralf Gold
Nature Reviews. Neurology|March 19, 2014
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MSAiden Haghikia, Ralf Gold
The American Journal of Pathology|April 17, 2010
The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulationAiden Haghikia, Ralf Gold
Journal of Neuroimmunology|November 3, 2009
Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous systemAiden Haghikia, Ralf Gold
Therapeutic Advances in Chronic Disease|July 20, 2016
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyRalf A Linker, Aiden Haghikia
Therapeutic Advances in Neurological Disorders|September 1, 2020
Multiple sclerosis and nutrition: back to the future?Ralf Gold, Xavier Montalban, Aiden Haghikia
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2016
Active immunotherapy may delay disability in progressive MSAiden Haghikia, Ralf Gold
MMW Fortschritte Der Medizin|September 7, 2013
[Multiple sclerosis: oral drugs]Aiden Haghikia, Ralf Gold
European Journal of Neurology|February 9, 2021
From many, one: A call for meta-cohorts in neuromuscular ultrasoundStefanie Schreiber, Aiden Haghikia
JAMA Neurology|March 9, 2016
Positive Effect on Multiple Sclerosis With Treatment of Metabolic SyndromeAiden Haghikia, Ralf Gold
Experimental Neurology|April 14, 2009
Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?Aiden Haghikia, Ralf Gold
Nature Reviews. Neurology|March 19, 2014
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MSAiden Haghikia, Ralf Gold
The American Journal of Pathology|April 17, 2010
The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulationAiden Haghikia, Ralf Gold
Journal of Neuroimmunology|November 3, 2009
Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous systemAiden Haghikia, Ralf Gold
Therapeutic Advances in Chronic Disease|July 20, 2016
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyRalf A Linker, Aiden Haghikia
Therapeutic Advances in Neurological Disorders|September 1, 2020
Multiple sclerosis and nutrition: back to the future?Ralf Gold, Xavier Montalban, Aiden Haghikia
Pageof 16